UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Iyer L, Das S, Janisch L, Wen M, Ram√≠rez J, Karrison T, Fleming GF, Vokes EE, Schilsky RL, Ratain MJ. ( 2002) The pharmacogenomics journal 2(1):43-7 PMID:11990381